ASHP CEO Meets with HHS Secretary and White House Officials on Change Healthcare Cyberattack

Published: March 12, 2024
Advocacy Breaking News

Today, ASHP CEO Paul W. Abramowitz participated in a discussion with Department of Health and Human Services (HHS) Secretary Xavier Becerra and senior White House officials regarding the fallout from the Change Healthcare cyberattack.

ASHP's advocacy, including a recent letter to Secretary Becerra, has emphasized the need to ensure that pharmacies will be made whole for medications dispensed, and cost-sharing collected, based on good faith efforts to ensure continuity of patient care.

ASHP has also called on HHS to ensure pharmacists and other providers will be held harmless for data breaches attributable to the cyberattack, and that for the purposes of audits and surveys, the period of a cyberattack is treated with leniency, to ensure that providers are not punished for lapses that were no fault of their own.

Last week, HHS announced actions it is taking, including some recommended by ASHP in its letter to HHS, to help providers get paid for services following the unprecedented cyberattack. HHS has provided information on how providers can access accelerated payments until the service disruptions to claims submission are fully resolved.

Read Abramowitz’s recent blog about the cyberattack to learn more about steps ASHP is taking in response.

Posted March 12, 2024

Advance Your Professional Development

View Other Products

Free Board Exam Prep Resources

The Review & Recertification Reward Program (RRRP) includes free access to exam preparation material + enrollment in a recertification plan billed monthly ($10) during your initial recertification cycle. For ASHP members only.

Learn More
Review & Recertification Reward Program (RRRP)

New Edition Available to Order

AHFS Drug Information® 2024 contains the most dependable drug information available—all in one place. It is the most comprehensive evidence-based source of drug information complete with therapeutic guidelines and off-label uses.

Order Today
AHFS 2024 Drug Information